Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase
(Adnkronos) – TOKYO, Feb. 22, 2023 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the development of a new
